Strides Acquires 18 ANDAs From Pharmaceutics
Deal Also Includes Exclusive Rights To Levothyroxine Candidate
Executive Summary
Strides has acquired 18 ANDAs from Pharmaceutics International, as well as exclusive marketing rights to a levothyroxine sodium candidate. Through this agreement, the Indian company plans to expand its niche offerings.